Baxter International reported $790M in Selling and Administration Expenses for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Selling And Administration Expenses Change
Abbott ABT:US $ 2.79B 158M
Abiomed ABMD:US $ 109.6M 1.99M
Atricure ATRC:US $ 56.12M 2.41M
Avanos Medical Inc AVNS:US $ 90.1M 14.9M
Baxter International BAX:US $ 790M 90M
Becton, Dickinson and BDX:US $ 1.23B 9M
Boston Scientific BSX:US $ 1.06B 93M
Cardiovascular Systems CSII:US $ 41.68M 1.28M
Cooper Companies COO:US $ 309.6M 7.3M
Cryolife CRY:US $ 36.33M 4.2M
Dexcom DXCM:US $ 220.9M 14.2M
Globus Medical GMED:US $ 100.75M 5.81M
Halozyme Therapeutics HALO:US $ 13.83M 60K
Inogen INGN:US $ 43.23M 2.65M
Insulet PODD:US $ 128.7M 7M
Integra Lifesciences IART:US $ 151.02M 4.66M
Masimo MASI:US $ 108.9M 4.79M
Quest Diagnostics DGX:US $ 416M 26M
Stryker SYK:US $ 1.5B 6M
Tandem Diabetes Care TNDM:US $ 73.27M 1.77M
Terumo 4543:JP 67.15B 3.63B